DeSantis CE et al. Breast cancer statistics, 2019 CA: A Cancer Journal for Clinicians, 2019. 69(6): pp. 438–451.
Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.
Perou CM, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52.
Article CAS PubMed Google Scholar
Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708–28.
Article CAS PubMed Google Scholar
Goldhirsch A, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast Cancer 2013. Ann Oncol. 2013;24(9):2206–23.
Article CAS PubMed PubMed Central Google Scholar
Polyak K. Heterogeneity in breast cancer. J Clin Investig. 2011;121(10):3786–8.
Article CAS PubMed PubMed Central Google Scholar
Sørlie T, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–74.
Article PubMed PubMed Central Google Scholar
Schnitt SJ. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol. 2010;23:S60–4.
Goldhirsch A, et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast Cancer 2011. Ann Oncol. 2011;22(8):1736–47.
Article CAS PubMed PubMed Central Google Scholar
Ma CX, Bose R, Ellis MJ. Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer, in Novel Biomarkers in the Continuum of Breast Cancer, V. Stearns, Editor. 2016, Springer International Publishing: Cham. pp. 125–154.
Yoon K-H, et al. Effect of Estrogen Receptor Expression Level and hormonal therapy on prognosis of early breast Cancer. Cancer Res Treat. 2022;54(4):1081–90.
Article CAS PubMed Google Scholar
Hanker AB, Sudhan DR, Arteaga CL. Overcoming Endocr Resist Breast Cancer Cancer Cell. 2020;37(4):496–513.
D’Souza A, Spicer D, Lu J. Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer. J Hematol Oncol. 2018;11(1):80.
Article PubMed PubMed Central Google Scholar
Neve RM, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10(6):515–27.
Article CAS PubMed PubMed Central Google Scholar
Sachs N, et al. A living biobank of breast Cancer Organoids captures Disease Heterogeneity. Cell. 2018;172(1–2):373–e38610.
Article CAS PubMed Google Scholar
Dekkers JF, et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021;16(4):1936–65.
Article CAS PubMed PubMed Central Google Scholar
Turrell FK, et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER(+) breast cancer metastatic relapse. Nat Cancer. 2023;4(4):468–84.
Article CAS PubMed PubMed Central Google Scholar
Perez-Lanzon M et al. New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma. J Immunother Cancer, 2023. 11(6).
Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407–18.
Article CAS PubMed Google Scholar
Corrò C, Novellasdemunt L, Li VSW. A brief history of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151–65.
Article PubMed PubMed Central Google Scholar
Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell. 2015;163(1):39–53.
Article CAS PubMed PubMed Central Google Scholar
Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst. 2013;105(7):452–8.
Article CAS PubMed PubMed Central Google Scholar
Zhou Y, et al. Experimental mouse models for translational human cancer research. Front Immunol. 2023;14:1095388.
Article CAS PubMed PubMed Central Google Scholar
Li Z, Wei L, Ce-Shi C. Breast cancer animal models and applications. Zoological Res. 2020;41(5):477.
Cameron DA, et al. Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat. 1997;45(2):99–107.
Article CAS PubMed Google Scholar
Fleming JM, et al. Local regulation of human breast xenograft models. J Cell Physiol. 2010;224(3):795–806.
Article CAS PubMed PubMed Central Google Scholar
Hartman J, et al. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 2006;66(23):11207–13.
Article CAS PubMed Google Scholar
Kim MH, et al. Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells. Sci Rep. 2021;11(1):22113.
Article CAS PubMed PubMed Central Google Scholar
Sflomos G, et al. A preclinical model for ERα-Positive breast Cancer points to the epithelial microenvironment as determinant of Luminal phenotype and hormone response. Cancer Cell. 2016;29(3):407–22.
Article CAS PubMed Google Scholar
Jiang G, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. BMC Genomics. 2016;17(Suppl 7):525.
Article PubMed PubMed Central Google Scholar
Kao J, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE. 2009;4(7):e6146.
Article PubMed PubMed Central Google Scholar
Kenny PA, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007;1(1):84–96.
Article CAS PubMed PubMed Central Google Scholar
Wen Y, et al. Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature. Brief Bioinform. 2017;18(3):426–40.
Zhu Y, et al. Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. Int J Oncol. 2006;29(6):1581–9.
留言 (0)